NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
1.250
+0.130 (11.61%)
At close: Aug 13, 2025, 4:00 PM
1.250
0.00 (-0.01%)
After-hours: Aug 13, 2025, 7:39 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $30.75 million as of August 13, 2025. Its market cap has increased by 110.66% in one year.
Market Cap
30.75M
Enterprise Value
30.30M
1-Year Change
110.66%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $30.75M, a decrease of -52.40%. That is a compound annual growth rate of -18.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 27.55M | -0.71% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |